EUVIMEDEUVIMED entdecken
Open Access

Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation

Yu Kawakami, Ikuo Takazawa, Merritt L Fajt, Kazumi Kasakura, Joseph Lin, Julienne Ferrer, David B Kantor, Wanda Phipatanakul, Peter W Heymann, Chris A Benedict, Yuko Kawakami, Toshiaki Kawakami

Journal of Allergy and Clinical Immunology · 2023

DOI: 10.1016/j.jaci.2023.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Yu Kawakami und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Allergic Diseases, La Jolla Institute for Immunology, La Jolla, Calif. Hauptthemen laut MEDLINE: Asthma, Enterovirus Infections, Picornaviridae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Histamine-releasing factor (HRF) is implicated in allergic diseases. We previously showed its pathogenic role in murine models of asthma. OBJECTIVE: We aim to present data analysis from 3 separate human samples (sera samples from asthmatic patients, nasal washings from rhinovirus [RV]-infected individuals, and sera samples from patients with RV-induced asthma exacerbation) and 1 mouse sample to investigate correlates of HRF function in asthma and virus-induced asthma exacerbations. METHODS: Total IgE and HRF-reactive IgE/IgG as well as HRF in sera from patients with mild/moderate asthma or severe asthma (SA) and healthy controls (HCs) were quantified by ELISA. HRF secretion in culture media from RV-infected adenovirus-12 SV40 hybrid virus transformed human bronchial epithelial cells and in nasal washings from experimentally RV-infected subjects was analyzed by Western blotting. HRF-reactive IgE/IgG levels in longitudinal serum samples from patients with asthma exacerbations were also quantified. RESULTS: HRF-reactive IgE and total IgE levels were higher in patients with SA than in HCs, whereas HRF-reactive IgG (and IgG1) level was lower in asthmatic patients versus HCs. In comparison with HRF-reactive IgElow asthmatic patients, HRF-reactive IgEhigh asthmatic patients had a tendency to release more tryptase and prostaglandin D2 on anti-IgE stimulation of bronchoalveolar lavage cells. RV infection induced HRF secretion from adenovirus-12 SV40 hybrid virus transformed bronchial epithelial cells, and intranasal RV infection of human subjects induced increased HRF secretion in nasal washes. Asthmatic patients had higher levels of HRF-reactive IgE at the time of asthma exacerbations associated with RV infection, compared with those after the resolution. This phenomenon was not seen in asthma exacerbations without viral infections. CONCLUSIONS: HRF-reactive IgE is higher in patients with SA. RV infection induces HRF secretion from respiratory epithelial cells both in vitro and in vivo. These results suggest the role of HRF in asthma severity and RV-induced asthma exacerbation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaEnterovirus InfectionsPicornaviridae InfectionsHumansAnimalsMiceHistamineRhinovirusImmunoglobulin EImmunoglobulin G

Stichwörter der Autor:innen

AsthmaHRFIgEIgGasthma exacerbationrhinovirus

Substanzen

HistamineImmunoglobulin EImmunoglobulin G

Autor:innen und Institutionen

  • Laboratory of Allergic Diseases, La Jolla Institute for Immunology, La Jolla, Calif.
  • Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
  • Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Children's Hospital, Boston, Mass.
  • Department of Immunology, Children's Hospital, Boston, Mass.
  • Asthma and Allergic Diseases Center, University of Virginia, Charlottsville, Va; Division of Pediatric Respiratory Medicine, University of Virginia, Charlottsville, Va.
  • Benedict Laboratory, Center for Autoimmunity and Inflammation and Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, Calif.

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NICHD NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Kawakami, Y., Takazawa, I., Fajt, M. L., Kasakura, K., Lin, J., Ferrer, J., Kantor, D. B., Phipatanakul, W., Heymann, P. W., Benedict, C. A., Kawakami, Y., & Kawakami, T. (2023). Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.04.021

Vancouver

Kawakami Y, Takazawa I, Fajt ML, Kasakura K, Lin J, Ferrer J, et al. Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.04.021

BibTeX
@article{Kawakami2023,
  author = {Kawakami, Yu and Takazawa, Ikuo and Fajt, Merritt L and Kasakura, Kazumi and Lin, Joseph and Ferrer, Julienne and Kantor, David B and Phipatanakul, Wanda and Heymann, Peter W and Benedict, Chris A and Kawakami, Yuko and Kawakami, Toshiaki},
  title = {Histamine-releasing factor in severe asthma and rhinovirus-associated asthma exacerbation},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  doi = {10.1016/j.jaci.2023.04.021}
}
Kostenlos starten →